Arkema stock edges lower while investors watch margins after latest half-year figures

Arkema stock (ISIN FR0010313833) was quoted at about EUR 56.90 on Euronext Paris as of September 18, 2026, leaving the specialty chemicals group modestly below its closing level from September 16, 2026 and broadly in line with its recent trading range.

Half-year figures frame the story

Arkema, a France-based specialty chemicals company, remains in the spotlight for investors largely because of its most recent half-year results, which set the tone for expectations on margins and cash generation in 2026. Per the company’s reporting for the first half of 2026, Arkema generated several billion euros of revenue over the six-month period, with performance shaped by both volume trends and pricing discipline in its key segments such as adhesives, advanced materials and coatings; these figures were published via the investor-relations channel of Arkema on a date within the latest reporting cycle, and they represent the most recent consolidated view of the group’s operations and profitability.

In that first-half 2026 report, Arkema’s earnings metrics showed the typical sensitivity of specialty chemicals to input costs and demand cycles. The company reported an earnings before interest, taxes, depreciation and amortization (EBITDA) margin that remained in the mid- to high-single-digit range for the half-year, and investors closely watched how this margin compared with the prior-year period, which saw a more favorable pricing backdrop. The half-year comparison indicated that revenue was only slightly below the level recorded in the first half of 2025, while the EBITDA margin compressed by more than 100 basis points as higher energy and feedstock costs weighed on profitability, underscoring why margin resilience is a central theme for Arkema stock at this stage.

Revenue mix and margin comparison

The half-year data are especially important because they show where Arkema is growing and where it is under pressure. For the first half of 2026, Arkema’s advanced materials and adhesives businesses accounted for a significant share of group revenue, reflecting demand from construction, automotive and electronics customers. Revenue in these segments grew by a low- to mid-single-digit percentage versus the first half of 2025, while more cyclical units such as certain commodity-related products saw declines compared with the prior year, producing a mixed picture when investors look at top-line growth across the portfolio.

On the margin side, the quantified comparison is clear: while Arkema kept revenue broadly stable compared with the first half of 2025, EBITDA and operating profit declined by a double-digit percentage, and the EBITDA margin contracted by more than 100 basis points over the same period. That shift, visible in the company’s reporting for H1 2026, highlights how even relatively small changes in pricing and input costs can translate into noticeable differences in earnings for a chemicals group. For investors, the key takeaway is that Arkema needs to continue focusing on pricing discipline and cost efficiency in the second half of 2026 to defend profitability.

Stock level and investor perspective

With Arkema stock trading around EUR 56.90 on Euronext Paris as of September 18, 2026, the shares sit below the company’s recent closing level from September 16, 2026 but still within the middle of their 52-week trading corridor, which spans several tens of euros between the low and the high over the last year. That price level implies a market capitalization in the multi-billion-euro range, underlining Arkema’s position as a mid- to large-cap player in the European specialty chemicals space. For investors, the current share price reflects both the margin pressure seen in the latest half-year figures and the expectation that Arkema can gradually improve profitability as input costs normalize and its higher-value segments grow.

More news and analyses on Arkema stock